(Q46007260)

English

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Mohammed Milhem

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Janice P Dutcher

33

object named as

Janice P Dutcher

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Joseph I Clark

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Michael K K Wong

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Howard L Kaufman

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Gregory A Daniels

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Michael A Morse

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

David F McDermott

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Sanjiv S Agarwala

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Lionel D Lewis

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

John H Stewart

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ulka Vaishampayan

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Brendan Curti

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

René Gonzalez

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jose Lutzky

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Venkatesh Rudraptna

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Lee D Cranmer

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ralph J Hauke

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Gerald Miletello

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Asim Amin

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

John M Richart

21

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Mayer Fishman

22

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Sigrun Hallmeyer

23

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Sapna P Patel

24

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Peter Van Veldhuizen

25

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Neeraj Agarwal

26

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Bret Taback

27

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jonathan S Treisman

28

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Marc S Ernstoff

29

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jessica C Perritt

30

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Hong Hua

31

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Tharak B Rao

32

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Sandra Aung

34

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

language of work or name

0 references

publication date

29 October 2016

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Clinical Genitourinary Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

31-41.e4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose interleukin-2 therapy for metastatic renal cell carcinoma: a contemporary experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current algorithms and prognostic factors in the treatment of metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2).

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma: current status and future prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2014

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27916626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CLGC.2016.10.008

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916626%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46007260&oldid=1573060241"